1
|
|
Milone M, Elmore U, Manigrasso M, Ortenzi M, Botteri E, Arezzo A, Silecchia G, Guerrieri M, De Palma GD, Agresta F; ERCOLE Study Group. ERas and COLorectal endoscopic surgery: an Italian society for endoscopic surgery and new technologies (SICE) national report. Surg Endosc 2022;36:7619-27. [PMID: 35501602 DOI: 10.1007/s00464-022-09212-y] [Cited by in Crossref: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Indexed: 02/07/2023]
Abstract
BACKGROUND Several reports demonstrated a strong association between the level of adherence to the protocol and improved clinical outcomes after surgery. However, it is difficult to obtain full adherence to the protocol into clinical practice and has still not been identified the threshold beyond which improved functional results can be reached. METHODS The ERCOLE (ERas and COLorectal Endoscopic surgery) study was as a cohort, prospective, multi-centre national study evaluating the association between adherence to ERAS items and clinical outcomes after minimally invasive colorectal surgery. The primary endpoint was to associate the percentage of ERAS adherence to functional recovery after minimally invasive colorectal cancer surgery. The secondary endpoints of the study was to validate safety of the ERAS programme evaluating complications' occurrence according to Clavien-Dindo classification and to evaluate the compliance of the Italian surgeons to each ERAS item. RESULTS 1138 patients were included. Adherence to the ERAS protocol was full only in 101 patients (8.9%), > 75% of the ERAS items in 736 (64.7%) and > 50% in 1127 (99%). Adherence to > 75% was associated with a better functional recovery with 90.2 ± 98.8 vs 95.9 ± 33.4 h (p = 0.003). At difference, full adherence to the ERAS components 91.7 ± 22.1 vs 92.2 ± 31.6 h (p = 0.8) was not associated with better recovery. CONCLUSIONS Our results were encouraging to affirm that adherence to the ERAS program up to 75% could be considered satisfactory to get the goal. Our study could be considered a call to simplify the ERAS protocol facilitating its penetrance into clinical practice.
Collapse
|
2
|
|
Milone M, Elmore U, Manigrasso M, Ortenzi M, Botteri E, Arezzo A, Silecchia G, Guerrieri M, De Palma GD, Agresta F, Agresta F, Pizza F, D’antonio D, Amalfitano F, Selvaggi F, Sciaudone G, Selvaggi L, Prando D, Cavallo F, Guerrieri M, Ortenzi M, Lezoche G, Cuccurullo D, Tartaglia E, Sagnelli C, Coratti A, Tribuzi A, Di Marino M, Anania G, Bombardini C, Zago MP, Tagliabue F, Burati M, Di Saverio S, Colombo S, Adla SE, De Luca M, Zese M, Parini D, Prosperi P, Alemanno G, Martellucci J, Olmi S, Oldani A, Uccelli M, Bono D, Scaglione D, Saracco R, Podda M, Pisanu A, Murzi V, Agrusa A, Buscemi S, Muttillo IA, Picardi B, Muttillo EM, Solaini L, Cavaliere D, Ercolani G, Corcione F, Peltrini R, Bracale U, Lucchi A, Vittori L, Grassia M, Porcu A, Perra T, Feo C, Angelini P, Izzo D, Ricciardelli L, Trompetto M, Gallo G, Luc AR, Muratore A, Calabrò M, Cuzzola B, Barberis A, Costanzo F, Angelini G, Ceccarelli G, Rondelli F, De Rosa M, Cassinotti E, Boni L, Baldari L, Bianchi PP, Formisano G, Giuliani G, Ceretti AAP, Mariani NM, Giovenzana M, Farfaglia R, Marcianò P, Arizzi V, Piccoli M, Pecchini F, Pattacini GC, Botteri E, Vettoretto N, Guarnieri C, Laface L, Abate E, Casati M, Feo C, Fabri N, Pesce A, Maida P, Marte G, Abete R, Casali L, Marchignoli A, Dall’aglio M, Scabini S, Pertile D, Aprile A, Andreuccetti J, Di Leo A, Crepaz L, Maione F, Vertaldi S, Chini A, Rosati R, Puccetti F, Maggi G, Cossu A, Sartori A, De Luca M, Piatto G, Perrotta N, Celiento M, Scorzelli M, Pilone V, Tramontano S, Calabrese P, Sechi R, Cillara N, Putzu G, Podda MG, Montuori M, Pinotti E, Sica G, Franceschilli M, Sensi B, Degiuli M, Reddavid R, Puca L, Farsi M, Minuzzo A, Gia E, Baiocchi GL, Ranieri V, Celotti A, Bianco F, Grassia S, Novi A, ERCOLE Study Group. ERas and COLorectal endoscopic surgery: an Italian society for endoscopic surgery and new technologies (SICE) national report. Surg Endosc 2022;36:7619-7627. [DOI: 10.1007/s00464-022-09212-y] [Cited by in Crossref: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Indexed: 03/10/2023]
Abstract
Abstract
Background
Several reports demonstrated a strong association between the level of adherence to the protocol and improved clinical outcomes after surgery. However, it is difficult to obtain full adherence to the protocol into clinical practice and has still not been identified the threshold beyond which improved functional results can be reached.
Methods
The ERCOLE (ERas and COLorectal Endoscopic surgery) study was as a cohort, prospective, multi-centre national study evaluating the association between adherence to ERAS items and clinical outcomes after minimally invasive colorectal surgery. The primary endpoint was to associate the percentage of ERAS adherence to functional recovery after minimally invasive colorectal cancer surgery. The secondary endpoints of the study was to validate safety of the ERAS programme evaluating complications’ occurrence according to Clavien-Dindo classification and to evaluate the compliance of the Italian surgeons to each ERAS item.
Results
1138 patients were included. Adherence to the ERAS protocol was full only in 101 patients (8.9%), > 75% of the ERAS items in 736 (64.7%) and > 50% in 1127 (99%). Adherence to > 75% was associated with a better functional recovery with 90.2 ± 98.8 vs 95.9 ± 33.4 h (p = 0.003). At difference, full adherence to the ERAS components 91.7 ± 22.1 vs 92.2 ± 31.6 h (p = 0.8) was not associated with better recovery.
Conclusions
Our results were encouraging to affirm that adherence to the ERAS program up to 75% could be considered satisfactory to get the goal. Our study could be considered a call to simplify the ERAS protocol facilitating its penetrance into clinical practice.
Collapse
|
5
|
|
Lombardi PM, Mazzola M, Giani A, Baleri S, Maspero M, De Martini P, Gualtierotti M, Ferrari G. ERAS pathway for gastric cancer surgery: adherence, outcomes and prognostic factors for compliance in a Western centre. Updates Surg 2021. [PMID: 34018142 DOI: 10.1007/s13304-021-01093-5] [Cited by in Crossref: 1] [Cited by in RCA: 2] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Indexed: 12/13/2022]
Abstract
Adherence to an ERAS program guarantees an evidence-based approach for patient care, but the compliance to ERAS in patients undergoing surgery for gastric cancer in Western countries has not been clearly investigated. Our Institution has implemented an ERAS pathway (EP) for gastric surgery, composed of 24 items, since December 2016. We retrospectively analyzed the data of all consecutive patients undergoing surgery with curative intent for gastric cancer between January 2017 and December 2019 at our Institution, and were eligible for our EP. The primary endpoint was patients' compliance to the EP. Secondary endpoints were patients' adherence to each ERAS item and detection of variables associated with compliance failure. Seventy-three patients were included. Among these, 75.3% completed the EP, with a median number of items accomplished per patient of 21. Items with critical adherence were restrictive intraoperative fluid infusion (37%), avoidance of abdominal drain (14%), first clear liquid intake (67%), first solid food intake (48%). At univariate analysis age > 75 years, ASA > 2 and total gastrectomy were associated with failure to complete the EP. At multivariate analysis, ASA Score > 2 was the only preoperative factor associated with EP failure. Application of an ERAS program for malignant gastric surgery seems to be feasible with an acceptable completion rate in a tertiary referral Western centre. Preoperative factors, such as old age, advanced stage at diagnosis and neoadjuvant chemotherapy should not be considered as exclusion criteria for ERAS.
Collapse
|
6
|
|
Catarci M, Benedetti M, Maurizi A, Spinelli F, Bernacconi T, Guercioni G, Campagnacci R. ERAS pathway in colorectal surgery: structured implementation program and high adherence for improved outcomes. Updates Surg 2021;73:123-37. [PMID: 33094366 DOI: 10.1007/s13304-020-00885-5] [Cited by in Crossref: 3] [Cited by in RCA: 3] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Indexed: 01/30/2023]
Abstract
Although there is clear evidence that an Enhanced Recovery After Surgery (ERAS) program in colorectal surgery leads to significantly reduced morbidity rates and length of hospital stay (LOS), it is still unclear what modalities and levels of implementation of the program are necessary to achieve these results. The purpose of this study is to analyze the methods and results of the first year of structured implementation of a colorectal ERAS program in two surgical units of the Azienda Sanitaria Unica Regionale (ASUR) Marche in Italy. A two-center observational study on a prospectively maintained database was performed on 196 consecutive colorectal resections (excluding emergencies and American Society of Anesthesiologists class > III cases) over a 1-year period. More than 50 variables including adherence to the individual items of the ERAS program were considered. Primary outcomes were overall morbidity, major morbidity, mortality and anastomotic leakage rates; secondary outcomes were LOS, re-admission and re-operation. The results were evaluated by univariate and multivariate analyses through logistic regression. After a median follow-up of 39.5 days, we recorded complications in 72 patients (overall morbidity 36.7%), major complications in 14 patients (major morbidity 7.1%), 6 deaths (mortality 3.1%), anastomotic dehiscence in 9 cases (4.9%), mean overall LOS of 6.6 days, 10 readmissions (5.1%) and 13 reoperations (6.7%). The mean adherence rate to the items of the ERAS program was 85.4%, showing a significant dose-effect curve for overall and major morbidity rates, anastomotic leakage rates and LOS. The implementation methods of a colorectal ERAS program in this study led to a high adherence (> 80%) to the program items. High adherence had significant effects also on major morbidity and anastomotic leakage rates.
Collapse
|